Lipoprotein disorders causes: Difference between revisions

Jump to navigation Jump to search
Line 74: Line 74:
{|style="width:80%; height:100px" border="1"
{|style="width:80%; height:100px" border="1"
|style="height:100px"; style="width:25%" border="1" bgcolor="LightSteelBlue" | '''Cardiovascular'''
|style="height:100px"; style="width:25%" border="1" bgcolor="LightSteelBlue" | '''Cardiovascular'''
|style="height:100px"; style="width:75%" border="1" bgcolor="Beige" | No underlying causes
|style="height:100px"; style="width:75%" border="1" bgcolor="Beige" | [[Alagille syndrome]]
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
Line 102: Line 102:
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Gastroenterologic'''
| '''Gastroenterologic'''
|bgcolor="Beige"| [[Cholestatic jaundice]], [[Intrahepatic cholestasis]], [[Malignant hepatopathy]], [[Pancreatitis]]
|bgcolor="Beige"| [[Cholestatic jaundice]], [[Intrahepatic cholestasis]], [[Malignant hepatopathy]], [[Pancreatitis]], [[Alagille syndrome]]
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
Line 122: Line 122:
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Musculoskeletal / Ortho'''
| '''Musculoskeletal / Ortho'''
|bgcolor="Beige"| No underlying causes
|bgcolor="Beige"| [[Smith-Lemli-Opitz syndrome]]
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Neurologic'''
| '''Neurologic'''
|bgcolor="Beige"| No underlying causes
|bgcolor="Beige"| [[Growth hormone secreting pituitary adenoma]]
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Nutritional / Metabolic'''
| '''Nutritional / Metabolic'''
|bgcolor="Beige"| [[Dysglobulinemia]], [[LDL receptor deficiency]], [[Omega-3 polyunsaturated fatty acids]], [[Selenium deficiency]], [[Vitamin E deficiency]]
|bgcolor="Beige"| [[Dysglobulinemia]], [[LDL receptor deficiency]], [[Omega-3 polyunsaturated fatty acids]], [[Selenium deficiency]], [[Vitamin E deficiency]], [[Smith-Lemli-Opitz syndrome]], [[Apolipoprotein C-II deficiency]], [[Apoprotein E deficiency]], [[Carnitine palmitoyltransferase 1 deficiency]], [[Familial isolated vitamin E deficiency]], [[Fructose-1, 6-diphosphatase deficiency]], [[Glycogen storage diseases]], [[Lecithin cholesterol acyltransferase deficiency]], [[Lipoprotein lipase deficiency]], [[Niemann-Pick disease ]], [[Primary hypolipoproteinemia]]
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
Line 158: Line 158:
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Renal / Electrolyte'''
| '''Renal / Electrolyte'''
|bgcolor="Beige"| [[Chronic renal failure]], [[Nephrotic syndrome]]
|bgcolor="Beige"| [[Chronic renal failure]], [[Nephrotic syndrome]], [[Alagille syndrome]]
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"

Revision as of 20:46, 26 October 2012

Lipoprotein Disorders Microchapters

Patient Information

Overview

Causes

Classification

Hyperlipoproteinemia
Hypolipoproteinemia

Treatment

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hardik Patel, M.D.

Overview

Hyperlipidemia can occur as either a primary event or secondary to some underlying disease. The primary hyperlipidemias include chylomicronemia, hypercholesterolemia, dysbetalipoproteinemia, hypertriglyceridemia, mixed hyperlipoproteinemia, and combined hyperlipoproteinemia. Other diseases, such as diabetes mellitus, pancreatitis, renal disease, and hypothyroidism, can cause the secondary form.

Causes

Primary Hyperlipidemia

Hyperlipoproteinemia type I

Hyperlipoproteinemia type II

Type IIa
  • Familial hypercholesterolemia
    • Sporadic (due to dietary factors)
    • Polygenic (multiple abnormalities in LDL metabolism)
    • Truly familial (as a result of a mutation in the LDL receptor gene on chromosome 19 (0.2% of the population), the apo B gene (0.2%) or the proprotein convertase subtilisin kexin 9 (PCSK9) gene (very rare))
Type IIb
  • Familial combined hyperlipoproteinemia (FCH)
    • Overproduction of hepatically-derived apo B-100 associated with VLDL
    • Overproduction of substrates, including triglycerides and acetyl-CoA
    • Decreased clearance of LDL

Hyperlipoproteinemia type III

  • Presence of apo E E2/E2 genotype resulting in cholesterol-rich VLDL (β-VLDL)

Hyperlipoproteinemia type IV

  • Familial hypertriglyceridemia
    • Genetic defect, which is passed on in an autosomal dominant fashion

Hyperlipoproteinemia type V

  • Very similar to type I, but with high VLDL in addition to chylomicrons
  • Associated with glucose intolerance and hyperuricemia

Familial lecithin-cholesterol acyltransferase (LCAT) deficiency[1]

  • Caused by mutations of the LCAT gene located on chromosome 16q22, which is passed on in an autosomal recessive fashion
  • Associated with corneal opacities, hemolytic anaemia, and proteinuria

Secondary Hyperlipidemia

Secondary to some underlying "non-lipid" etiology

Causes by Organ System

Cardiovascular Alagille syndrome
Chemical / poisoning No underlying causes
Dermatologic No underlying causes
Drug Side Effect Amprenavir, Atazanavir sulfate, Atypical antipsychotics, Bendrofluazide, Beta blockers, Bexarotene, Chenodeoxycholic acid, Chlorthalidone, Clofibrate, Colesevelam hydrochloride, Colestyramine, Combined oral contraceptive pill, Cyclopenthiazide, Danazol, Desvenlafaxine, Doxazosin, Ethanol, Etretinate, Fosamprenavir, Gestrinone, Hydrochlorothiazide, Interferon alpha, Isotretinoin, Linagliptin, Lopinavir, Mitotane, Nelfinavir, Prazosin, Progestagens, Propofol, Protease inhibitors, Ritonavir, Rosiglitazone, Saquinavir, Sirolimus, Temsirolimus, Testosterone, Thiazide diuretics, Tipranavir, Tocilizumab, Tofacitinib, Torcetrapib
Ear Nose Throat No underlying causes
Endocrine Cushing syndrome, Diabetes mellitus type 2, Hypothyroidism, Metabolic syndrome, Hypopituitarism
Environmental No underlying causes
Gastroenterologic Cholestatic jaundice, Intrahepatic cholestasis, Malignant hepatopathy, Pancreatitis, Alagille syndrome
Genetic Alagille syndrome, Alstrom syndrome, Analbuminaemia, Apolipoprotein C-II deficiency, Apoprotein E deficiency, Berardinelli-Seip congenital lipodystrophy, Carnitine palmitoyltransferase 1 deficiency, Chromosome 15q deletion, Familial alphalipoprotein deficiency, Familial defective apolipoprotein B-100, Familial hypertriglyceridaemia, Familial isolated vitamin E deficiency, Familial mixed hyperlipidemia, Fructose-1, 6-diphosphatase deficiency, Glycogen storage diseases, Lecithin cholesterol acyltransferase deficiency, Lipoprotein lipase deficiency, Niemann-Pick disease , Primary hyperlipoproteinemia , Primary hypolipoproteinemia, Smith-Lemli-Opitz syndrome, Werner syndrome
Hematologic No underlying causes
Iatrogenic Parenteral nutrition
Infectious Disease Sepsis
Musculoskeletal / Ortho Smith-Lemli-Opitz syndrome
Neurologic Growth hormone secreting pituitary adenoma
Nutritional / Metabolic Dysglobulinemia, LDL receptor deficiency, Omega-3 polyunsaturated fatty acids, Selenium deficiency, Vitamin E deficiency, Smith-Lemli-Opitz syndrome, Apolipoprotein C-II deficiency, Apoprotein E deficiency, Carnitine palmitoyltransferase 1 deficiency, Familial isolated vitamin E deficiency, Fructose-1, 6-diphosphatase deficiency, Glycogen storage diseases, Lecithin cholesterol acyltransferase deficiency, Lipoprotein lipase deficiency, Niemann-Pick disease , Primary hypolipoproteinemia
Obstetric/Gynecologic Pregnancy
Oncologic Growth hormone secreting pituitary adenoma
Opthalmologic No underlying causes
Overdose / Toxicity Amprenavir, Atazanavir sulfate, Atypical antipsychotics, Bendrofluazide, Beta blockers, Bexarotene, Chenodeoxycholic acid, Chlorthalidone, Clofibrate, Colesevelam hydrochloride, Colestyramine, Combined oral contraceptive pill, Cyclopenthiazide, Danazol, Desvenlafaxine, Doxazosin, Ethanol, Etretinate, Fosamprenavir, Gestrinone, Hydrochlorothiazide, Interferon alpha, Isotretinoin, Linagliptin, Lopinavir, Mitotane, Nelfinavir, Prazosin, Progestagens, Propofol, Protease inhibitors, Ritonavir, Rosiglitazone, Saquinavir, Sirolimus, Temsirolimus, Testosterone, Thiazide diuretics, Tipranavir, Tocilizumab, Tofacitinib, Torcetrapib
Psychiatric Anorexia nervosa
Pulmonary No underlying causes
Renal / Electrolyte Chronic renal failure, Nephrotic syndrome, Alagille syndrome
Rheum / Immune / Allergy Macrophage activation syndrome
Sexual No underlying causes
Trauma No underlying causes
Urologic No underlying causes
Dental No underlying causes
Miscellaneous Alcohol abuse, Benign symmetrical lipomatosis, Exercise, Hight fat diet, Obesity, Positive family history, Sedentary lifestyle , Stress, Tobacco smoking

Causes in Alphabetical Order


References

  1. McIntyre N (1988). "Familial LCAT deficiency and fish-eye disease". J Inherit Metab Dis. 11 Suppl 1: 45–56. PMID 3141686.
  2. Rosenson RS, Baker AL, Chow MJ, Hay RV (1990). "Hyperviscosity syndrome in a hypercholesterolemic patient with primary biliary cirrhosis". Gastroenterology. 98 (5 Pt 1): 1351–7. PMID 2323525.
  3. Zavaroni I, Dall'Aglio E, Alpi O, Bruschi F, Bonora E, Pezzarossa A; et al. (1985). "Evidence for an independent relationship between plasma insulin and concentration of high density lipoprotein cholesterol and triglyceride". Atherosclerosis. 55 (3): 259–66. PMID 3893447.
  4. O'Brien T, Dinneen SF, O'Brien PC, Palumbo PJ (1993). "Hyperlipidemia in patients with primary and secondary hypothyroidism". Mayo Clin Proc. 68 (9): 860–6. PMID 8371604.
  5. Hubert HB, Feinleib M, McNamara PM, Castelli WP (1983). "Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study". Circulation. 67 (5): 968–77. PMID 6219830.
  6. Facchini FS, Hollenbeck CB, Jeppesen J, Chen YD, Reaven GM (1992). "Insulin resistance and cigarette smoking". Lancet. 339 (8802): 1128–30. PMID 1349365.
  7. Henderson DC (2001). "Clozapine: diabetes mellitus, weight gain, and lipid abnormalities". J Clin Psychiatry. 62 Suppl 23: 39–44. PMID 11603884.
  8. Osser DN, Najarian DM, Dufresne RL (1999). "Olanzapine increases weight and serum triglyceride levels". J Clin Psychiatry. 60 (11): 767–70. PMID 10584766.


Template:WikiDoc Sources